Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
There continues to be controversy over the role of testosterone replacement therapy (TRT) in men with prostate cancer who are “hypogonadal” — i.e., men with very low testosterone levels — as a consequence of their treatment.
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: testosterone replacement, TRT | 1 Comment »
Today’s news reports deal with: Active surveillance management strategies and outcomes to date Life expectancy and the appropriateness of treatment Penile rehabilitation post-surgery Testosterone replacement therapy in prostate cancer patients
Filed under: Management, Treatment, Uncategorized | Tagged: active surveillance, life expectancy, penile rehabilitation, testosterone replacement, Treatment, TRT | Leave a Comment »
Today’s news reports include items on: Risk for prostate cancer Patient decisions about sexual functionality and prostate cancer treatment Whole gland and focal cryotherapy Testosterone replacement after prostate cancer therapy and other items.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: cryotherapy, decision process, focal, patient, risk, sexual function, testosterone replacement, Trelstar, TRT, UroCool™ | Leave a Comment »
Today’s news reports contain four key items: A review of the potential of phytochemicals in treatment of prostate cancer A Norwegian study on correlation between biopsy-based and post-surgical Gleason scores A retrospective study on risk for prostate cancer in men being treated with testosterone replacement therapy An announcement of new data on PSP94 in the [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, Gleason score, Miraculins, phytochemicals, PSP94, testosterone replacement, TRT | Leave a Comment »
In a separate post we have addressed the clinical significance of a finding of tertiary Gleason pattern 5 in a core (or cores) following prostate needle biopsy. Other reports, addressed below, deal with: Genomic markers for prostate cancer risk stratification Outcomes of men with “prevalent” as opposed to “incident” prostate cancer Quality of life of [...]
Filed under: Uncategorized | Tagged: genomic biomarkers, incident, prevalent, quality of life, testosterone replacement | Leave a Comment »
There’s a lot of news today, so we will break it into two sections for reading convenience. In Part A, we deal with information about: Physicial activity and prostate cancer risk Vasectomy and prostate cancer risk The use of surveillance and watchful waiting in men in Sweden A modification to Walsh’s nerve-sparing radical prostatectomy The [...]
Filed under: Drugs in development, Living with Prostate Cancer, Management, Prevention, Treatment, Uncategorized | Tagged: Add new tag, multimodal therapy, physical activity, radical prostatectomy, risk, surveillance, testosterone replacement, vasectomy | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site